Advanced Search

 

Study ID Status Title Patient Level Data
FLTA2002 Completed A Randomized, Double-Blind, Placebo-Controlled Trial of Fluticasone Propionate 500mcg BID or 1000mcg BID via Multi-Dose Powder Inhaler or Placebo with Optional Open-Label Fluticasone Propionate 1000mcg BID via Multi-Dose Powder Inhaler in Subjects with Chronic Oral Steroid-Dependent Asthma.
FLTA2003 Completed A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Comparative Trial of Inhaled Fluticasone Propionate 100mcg BID and 200mcg QD Via Multi-Dose Powder Inhaler, Beclomethasone Dipropionate 168mcg via Metered-Dose Inhaler, and Placebo in Adolescent and Adult Subjects With Mild to Moderate Asthma
FLTA2004 Completed A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Comparative Trial of Inhaled Fluticasone Propionate 100mcg BID and 200mcg QD Via Multi-Dose Powder Inhaler, Beclomethasone Dipropionate 168mcg via Metered-Dose Inhaler, and Placebo in Adolescent and Adult Subjects With Mild to Moderate Asthma
FLTA2005 Completed A randomized, double-blind, parallel group, comparative trial of inhaled fluticasone propionate via the multi-dose powder inhaler 250mcg BID, 500mcg QD and placebo in adolescent and adult subjects with mild to moderate asthma
FLTA2006 Completed A Randomized, Double-Blind, Double-Dummy, Parallel-Group Trial Assessing the Efficacy and Safety of Fluticasone Propionate 50 or 100mcg BID via the Multi-Dose Powder Inhaler, Fluticasone Propionate 50 or 100mcg BID via the Diskhaler and Placebo in Subjects Aged 4 to 11 Years…
FLTA2007 Completed A Stratified, Randomized, Double-Blind, Parallel-Group Trial Assessing the Efficacy and Safety of Fluticasone Propionate via the Multi-Dose Powder Inhaler 50mcg BID, 100mcg QD, and Placebo in Subjects Aged 4 to 11 Years With Chronic Asthma.
FLTA2008 Completed Open-Label Extension of a Randomized, Double-Blind, Parallel-Group Trial Assessing the Efficacy and Safety of FIuticasone Propionate via the Multi-Dose Powder Inhaler 100mcg BID, 200mcg QD, and Placebo in Subjects Aged 4 to 11 Years With Chronic Asthma
FLTA2016 Completed A stratified, randomized, double-blind, parallel-group, comparative trial of inhaled fluticasone propionate via the multi-dose powder inhaler 100mcg QD, 200mcg QD, 500mcg QD and placebo in adolescent and adult subjects with chronic asthma.
FLTA3001 Completed A Randomized, Double-Blind, Parallel-Group Trial to Assess the Long Term Safety of Fluticasone Propionate Inhalation Aerosol 100mcg BID and 500mcg BID Versus Placebo BID in Adult Subjects with Moderate Asthma
FLTA3010 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of fluticasone propionate aqueous nasal spray versus placebo followed by a six-month open-label safety extension in subjects with perennial nonallergic rhinitis
FLTA3014 Completed A Randomized, Double-Blind, Comparative Trial of Inhaled Fluticasone Propionate 250mcg BID With and Without a Spacer Device to Inhaled Fluticasone Propionate 100mcg BID Without a Spacer Device and Placebo With and Without a Spacer Device in Adolescent and Adult Subjects with Asthma
FLTA3014PK Completed Pharmacokinetic Report: A Randomized, Double-Blind, Comparative Trial of Inhaled Fluticasone Propionate 250mcg BID With and Without a Spacer Device to Inhaled Fluticasone Propionate 100mcg BID Without a Spacer Device and Placebo With and Without a Spacer Device in Adolescent and Adult Subjects W ...
FLTA3015 Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Trial Evaluating Safety and Efficacy of Salmeterol xinafoate and Fluticasone propionate Individually and in Combination in Subjects with Asthma
FLTA3020 Completed A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Comparative Trial of Inhaled Fluticasone Propionate 110mcg BID and 220mcg BID via Metered-Dose Inhaler Propelled by Propellants 11/12 or by GR106642X in Adolescent and Adult Subjects with Asthma
FLTA3022 Completed A Randomized, Double-Blind, Placebo-Controlled Comparative Trial of Fluticasone Propionate 440mcg BID or 880mcg BID versus Placebo Administered via Metered-Dose Inhaler in Propellant 11/12 or GR106642X in Adolescent and Adult Oral Corticosteroid Dependent Asthmatics.
FLTA3025 Completed A randomized, double-blind, parallel-group, comparative trial of inhaled fluticasone propionate 250mcg twice daily, 500mcg twice daily, and placebo twice daily via the DISKUS® inhaler in subjects with chronic obstructive pulmonary disease (COPD). Study Listed on ClinicalStudyDataRequest.com
FLTA4004 Completed Double-Blind, Double-Dummy, Randomized, Parallel-Group Comparison of the Efficacy and Safety Outcomes of Fluticasone Propionate Aqueous Nasal Spray Versus Encapsulated Loratadine Tablets Versus Placebo for Four Weeks in Subjects with Seasonal Allergic Rhinitis
FLTA4006 Completed Double-blind, double-dummy, randomized, parallel group comparison of the efficacy and safety of fluticasone proprionate aqueous nasal spray vs encapsulated loratadine tablets vs a combination of fluticasone proprionate and loratidine vs placebo for two weeks in subjects with seasonal allergic rh ...
FLTA4007 Completed A double-blind, double-dummy, randomized, placebo-controlled, parallel-group comparison of fluticasone propionate aqueous nasal spray and triamcinolone acetonide aqueous nasal spray in subjects with seasonal allergic rhinitis
FLTA4008 Completed A double-blind, double-dummy, randomized, placebo-controlled, parallel-group comparison of fluticasone propionate aqueous nasal spray and triamcinolone acetonide aqueous nasal spray in subjects with seasonal allergic rhinitis.
FLTA4021 Completed A Randomized, Double-Blind, Parallel-Group, Comparative Trial Evaluating Fluticasone Propionate (220mcgBID), Triamcinolone Acetonide (600mcg BID), and Fluticasone Propionate (88mcg BID) in Combination withSalmeterol Xinafoate (42mcg BID), Each Delivered Via A Metered-Dose Inhaler
FLTA4022 Completed A Randomized, Double-Blind, Parallel-Group, Comparative Trial Evaluating Fluticasone Propionate (220mcg BID), Triamcinolone Acetonide (600mcg BID), and Fluticasone Propionate (88mcg BID) in Combination with Salmeterol Xinafoate (42mcg BID), Each Delivered Via A Metered-Dose Inhaler, in Subjects with
FLTA4024 Completed Double-blind, double-dummy, randomized, parallel group comparison of fluticasone proprionate aqueous nasal spray versus encapsulated loratadine tablets versus a combination of fluticasone proprionate and loratadine versus placebo for two weeks in subjects with seasonal allergic rhinitis
FLTA4025 Completed A randomized, double-blind, placebo-controlled study examining the effect of fluticasone propionate aqueous nasal spray 200mcg QD used in conjunction with an antibiotic in allergic and nonallergic subjects with recurrent sinusitis
FLTA4030 Completed A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Comparative Study of Inhaled Fluticasone Propionate (88mcg BID) Versus Zafirlukast (20mg BID) in Subjects Who Are Currently Receiving Beta-Agonists Alone

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.